Close

Achieve Life Sciences (ACHV) Announces Allowance of U.S. Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of Addiction

Go back to Achieve Life Sciences (ACHV) Announces Allowance of U.S. Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of Addiction
(NASDAQ: ACHV) Delayed: 4.54 +0.04 (0.89%)
Previous Close $4.50    52 Week High
Open $4.52    52 Week Low
Day High $4.54    P/E N/A 
Day Low $4.45    EPS
Volume 31,736